LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza

Group 2 innate lymphoid cells (ILC2) are a relatively new class of innate immune cells. Lung ILC2 are early responders that secrete type 2 cytokines in response to danger ‘alarmin’ signals such as interleukin (IL)‐33 and thymic stromal lymphopoietin. Being an early source of type 2 cytokines, ILC2 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Clare M, Roy, Sreeja, Sun, Wei, Furuya, Andrea M, Wijesundara, Danushka K, Furuya, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Special Feature Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958247/
https://www.ncbi.nlm.nih.gov/pubmed/35356066
http://dx.doi.org/10.1002/cti2.1381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958247/
https://www.ncbi.nlm.nih.gov/pubmed/35356066
http://dx.doi.org/10.1002/cti2.1381

Ejemplares similares